These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25417936)

  • 1. Influence of protein formulation and carrier solution on asymmetrical flow field-flow fractionation: a case study of the plant-produced recombinant anthrax protective antigen pp-PA83.
    Palais C; Chichester JA; Manceva S; Yusibov V; Arvinte T
    J Pharm Sci; 2015 Feb; 104(2):612-7. PubMed ID: 25417936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of asymmetrical flow field-flow fractionation as a method for detecting protective antigen by direct recognition of size-increased target-captured nanoprobes.
    Shin K; Choi J; Cho JH; Yoon MY; Lee S; Chung H
    J Chromatogr A; 2015 Nov; 1422():239-246. PubMed ID: 26482872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical flow field-flow fractionation coupled with multi-angle light scattering and refractive index detections for characterization of ultra-high molar mass poly(acrylamide) flocculants.
    Leeman M; Islam MT; Haseltine WG
    J Chromatogr A; 2007 Nov; 1172(2):194-203. PubMed ID: 17961584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quaternary size distribution of soluble aggregates of glutathione-S-transferase-purified viral protein as determined by asymmetrical flow field flow fractionation and dynamic light scattering.
    Lipin DI; Lua LH; Middelberg AP
    J Chromatogr A; 2008 May; 1190(1-2):204-14. PubMed ID: 18395215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
    Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
    Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal aggregation of bovine serum albumin studied by asymmetrical flow field-flow fractionation.
    Yohannes G; Wiedmer SK; Elomaa M; Jussila M; Aseyev V; Riekkola ML
    Anal Chim Acta; 2010 Aug; 675(2):191-8. PubMed ID: 20800732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative characterization by asymmetrical flow field-flow fractionation of IgG thermal aggregation with and without polymer protective agents.
    Ma D; Martin N; Tribet C; Winnik FM
    Anal Bioanal Chem; 2014 Nov; 406(29):7539-47. PubMed ID: 25323742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale structural changes accompany binding of lethal factor to anthrax protective antigen: a cryo-electron microscopic study.
    Ren G; Quispe J; Leppla SH; Mitra AK
    Structure; 2004 Nov; 12(11):2059-66. PubMed ID: 15530370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing molar mass distributions and molecule structures of different chitosans using asymmetrical flow field-flow fractionation combined with multi-angle light scattering.
    Augsten C; Mäder K
    Int J Pharm; 2008 Mar; 351(1-2):23-30. PubMed ID: 17964095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP6 holds the key to the entry of anthrax toxin.
    Bann JG; Cegelski L; Hultgren SJ
    Cell; 2006 Mar; 124(6):1119-21. PubMed ID: 16564002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin.
    Rozanov DV; Golubkov VS; Strongin AY
    Int J Biochem Cell Biol; 2005 Jan; 37(1):142-54. PubMed ID: 15381157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of branched ultrahigh molar mass polymers by asymmetrical flow field-flow fractionation and size exclusion chromatography.
    Otte T; Pasch H; Macko T; Brüll R; Stadler FJ; Kaschta J; Becker F; Buback M
    J Chromatogr A; 2011 Jul; 1218(27):4257-67. PubMed ID: 21238968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved particle counting and size distribution determination of aggregated virus populations by asymmetric flow field-flow fractionation and multiangle light scattering techniques.
    McEvoy M; Razinkov V; Wei Z; Casas-Finet JR; Tous GI; Schenerman MA
    Biotechnol Prog; 2011; 27(2):547-54. PubMed ID: 21302365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.